Prime Capital Investment Advisors LLC Sells 2,528 Shares of Aflac Incorporated (NYSE:AFL)

Prime Capital Investment Advisors LLC lowered its stake in shares of Aflac Incorporated (NYSE:AFL) by 11.2% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 20,110 shares of the financial services provider’s stock after selling 2,528 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Aflac were worth $2,248,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. Dimensional Fund Advisors LP increased its position in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after purchasing an additional 285,576 shares during the last quarter. APG Asset Management N.V. grew its position in Aflac by 1.3% in the 2nd quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider’s stock valued at $202,437,000 after acquiring an additional 31,752 shares during the last quarter. Guinness Asset Management LTD grew its position in Aflac by 3.8% in the 3rd quarter. Guinness Asset Management LTD now owns 2,276,325 shares of the financial services provider’s stock valued at $254,382,000 after acquiring an additional 83,289 shares during the last quarter. ProShare Advisors LLC grew its position in Aflac by 5.6% in the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after acquiring an additional 117,504 shares during the last quarter. Finally, Truist Financial Corp grew its position in Aflac by 26.6% in the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after acquiring an additional 405,847 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Trading Down 0.2 %

Shares of NYSE AFL opened at $110.44 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. The stock has a market capitalization of $61.35 billion, a P/E ratio of 16.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.96. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50. The business has a fifty day moving average price of $110.36 and a 200 day moving average price of $99.14.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The firm had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same period in the prior year, the business posted $1.84 EPS. The firm’s quarterly revenue was down 40.4% on a year-over-year basis. Equities research analysts expect that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date is Wednesday, November 20th. Aflac’s dividend payout ratio (DPR) is presently 30.12%.

Analyst Ratings Changes

Several equities analysts have commented on the company. Truist Financial upped their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Wells Fargo & Company upped their price objective on Aflac from $106.00 to $107.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Morgan Stanley upped their price objective on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. UBS Group upped their target price on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Finally, Barclays started coverage on Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.